Natural Compound from Waterlily Shows Promise in Fighting Fatty Liver Disease

Herbs And Phytochemicals: With modern diets rich in fats and sugars, fatty liver disease, specifically Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is on the rise. MASLD, a serious condition often caused by high-fat, high-sugar diets, is marked by liver fat buildup and chronic inflammation. Without treatment, MASLD can escalate, resulting in severe complications like cirrhosis and even liver cancer. This Herbs and Phytochemicals news report discusses recent research that highlights a promising natural remedy derived from the snow-white waterlily, known scientifically as Nymphaea candida. Researchers from Xinjiang Medical University and the Xinjiang Institute of Materia Medica in China have been exploring the therapeutic potential of a phytochemical compound called isostrictiniin (ITN) extracted from this plant.


Natural Compound from Waterlily Shows Promise in Fighting Fatty Liver Disease

The Study: Examining Isostrictiniin’s Effectiveness
The researchers investigated how isostrictiniin impacts MASLD. Using a group of mice, they divided them into two categories: one on a normal diet and another fed a high-fat, high-sugar diet (HFSD) to induce MASLD. This article reports that after four weeks, the HFSD mice were further divided into subgroups, receiving different doses of isostrictiniin or atorvastatin, a cholesterol-lowering medication used for comparison. Over the next four weeks, scientists observed various health markers in the mice, including liver function, fat content, and inflammatory responses.
 
Key Findings on Isostrictiniin’s Protective Benefits
-Liver Protection and Fat Reduction
Isostrictiniin’s most noticeable effect was on liver health. Mice given ITN showed a significant reduction in liver weight and overall fat content compared to those on the HFSD diet without treatment. Researchers noticed that liver samples from treated mice had visibly less fat buildup, which was confirmed through microscopic examinations. This finding suggests that isostrictiniin may help reduce the risk of liver damage from diets high in fat and sugar.
 
-Improved Blood Lipid Profiles
Mice treated with isostrictiniin also displayed healthier blood lipid levels. The study revealed that ITN lowered triglycerides, total cholesterol, and LDL cholesterol, all markers associated with metabolic diseases. Interestingly, high doses of ITN raised HDL cholesterol, the "good" cholesterol that helps to protect the heart. This improvement in lipid profiles suggests that isostrictiniin could support overall metabolic health beyond just the liver.
 
-Enhanced Blood Sugar Control
Elevated blood sugar and insulin resistance are significant concerns for individuals with MASLD, as they can worsen the condition and increase the risk of diabetes. Isostrictiniin-treated mice had lower fasting blood glucose levels and improved insulin sensitivity, as shown by the HOMA-IR index. These results indicate that ITN might offer a dual benefit by helpin g manage both MASLD and blood sugar levels, reducing the risk of type 2 diabetes in people with fatty liver disease.
 
-Anti-inflammatory and Antioxidant Effects
One of the root causes of MASLD’s progression is inflammation and oxidative stress. Isostrictiniin demonstrated strong anti-inflammatory effects by lowering levels of inflammatory markers, including IL-6, TNF-α, and IL-1β, which were all elevated in the HFSD-fed mice. ITN also increased levels of antioxidants like superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) while reducing malondialdehyde (MDA), a marker of oxidative stress. These findings imply that isostrictiniin could protect liver cells from inflammation and oxidative damage, two key drivers of MASLD progression.
 
Mechanism of Action: The AMPK/SREBP-1c/ACC Pathway
Understanding how isostrictiniin works at a molecular level is essential for exploring its potential as a therapeutic option. Researchers focused on a cellular pathway known as AMPK/SREBP-1c/ACC, which plays a critical role in energy regulation and fat metabolism. The AMPK protein, often called the body's energy regulator, can reduce fat production when activated, while the proteins SREBP-1c and ACC promote fat synthesis and storage.
 
The study found that isostrictiniin activated AMPK in liver cells while reducing levels of SREBP-1c and ACC, thereby curbing fat accumulation. This dual action of reducing fat production and promoting fat breakdown makes isostrictiniin particularly promising in managing MASLD. By targeting the AMPK pathway, ITN could help prevent liver fat buildup and improve overall metabolic health.
 
A Promising Natural Treatment Option?
These results are significant as they reveal isostrictiniin’s potential in preventing and treating MASLD, particularly for people struggling to manage dietary and lifestyle changes. Currently, the primary MASLD treatments involve lifestyle modifications, such as exercise and a healthier diet, which many find challenging to maintain. This research introduces the possibility of an alternative treatment option derived from natural plant sources.
 
The scientists believe that isostrictiniin's effect on liver fat and inflammation offers a dual benefit that could make it a unique addition to current MASLD treatment approaches. Furthermore, its antioxidant properties could help reduce liver stress caused by the buildup of reactive molecules, enhancing liver function and preventing long-term damage.
 
Conclusion: A Step Forward in MASLD Management
The findings from this study, published in the peer-reviewed journal Nutrients, provide a promising outlook on isostrictiniin as a potential treatment for MASLD. With its multifaceted approach - reducing liver fat, improving blood sugar control, lowering inflammation, and providing antioxidant protection - this natural compound may offer a valuable tool for combating fatty liver disease. More research, particularly in human trials, will be necessary to confirm these benefits and fully understand the therapeutic potential of isostrictiniin.
 
As MASLD continues to affect millions worldwide, these findings underscore the importance of further exploring natural treatments that can help manage this condition effectively.
 
The study findings were published in the peer reviewed journal: Nutrients.
https://www.mdpi.com/2072-6643/16/22/3876
 
For the latest on Herbs And Phytochemicals, keep on logging on to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/italian-study-finds-that-aged-garlic-extract-reduces-inflammatory-genes-induced-by-covid-19-infections-or-vaccines
 
https://www.thailandmedical.news/news/the-phytochemical-trifolin-found-to-protect-the-heart-against-hypertension-damage